To understand whether ADM may be involved in CALCRL signaling in AML, we analyzed its expression in three different datasets of leukemic and hematopoietic cells at different stages of differentiation, including stem and progenitor cells, defined on a surface phenotype base (GSE24006, GSE117190 and GSE63270). This evidence concerns the gene ADM and acute myeloid leukemia.